Investor Relations

Corporate Profile

Insulet Corporation is an innovative medical device company based in Bedford, Massachusetts. It was founded in 2000 with the mission of improving the lives of people with diabetes. Specifically, through its revolutionary OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy.

Studies have demonstrated the advantages of insulin pump therapy over multiple daily insulin injections (MDI); these advantages include better glycemic control, fewer hypoglycemic events, reduced glycemic variability¹ and improved quality of life². Despite these benefits, most people still choose MDI therapy largely due to the complexity, cost and inconvenience of conventional pump technology...More ▼

Corporate Profile

Insulet Corporation is an innovative medical device company based in Bedford, Massachusetts. It was founded in 2000 with the mission of improving the lives of people with diabetes. Specifically, through its revolutionary OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy.

Studies have demonstrated the advantages of insulin pump therapy over multiple daily insulin injections (MDI); these advantages include better glycemic control, fewer hypoglycemic events, reduced glycemic variability¹ and improved quality of life². Despite these benefits, most people still choose MDI therapy largely due to the complexity, cost and inconvenience of conventional pump technology.

The OmniPod is a discreet and easy-to-use system that eliminates many of the issues associated with conventional pumps. Improvements include OmniPod's lack of tubing; automated, virtually pain-free insertion; and two straightforward parts that communicate wirelessly. By breaking down the barriers to insulin pump therapy, Insulet hopes to provide both a superior treatment option and life-long health benefits for people with diabetes.

^1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine.1993:329:977-986.

^2. Miaone, A, et al. OP 27 Psychological aspects of diabetes. Presented at the 43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam. 2007. Less ▲